Stem cells and nanotechnology in regenerative medicine and tissue engineering
Download as PPTX, PDF4 likes2,614 views
The document discusses the role of stem cells and nanotechnology in regenerative medicine and tissue engineering. It outlines various strategies such as cell therapy, biomaterial design, and bioactive factors to enhance tissue regeneration and highlights the importance of nanoscale interactions in controlling cell behavior. It concludes with a focus on developing advanced biocompatible materials for effective tissue repair without chronic immunosuppression.
Stem cells and nanotechnology in regenerative medicine and tissue engineering
- 1. STEM CELLS AND NANOTECHNOLOGY IN REGENERATIVE MEDICINE AND TISSUE ENGINEERINGHTTPS://WWW.RESEARCHGATE.NET/PROFILE/SITANSU_NANDA3 HTTP://SCHOLAR.GOOGLE.CO.KR/CITATIONS?USER=EPAML2OAAAAJ&HL=EN
- 2. CONTENTS ■ INTRODUCTION ■ TISSUE ENGINEERING AND REGENERATIVE MEDICINE STRATEGIES ■ Cell Therapy ■ Tissue Engineering and Biomaterials ■ Bioactive Factors in Tissue Engineering ■ NANOTECHNOLOGY IN REGENERATIVE MEDICINE AND TISSUE ENGINEERING ■ Introduction to Nanotechnology ■ Nano-Based Cell Tracking ■ 2D Nano topography ■ 3D Nano scaffolds (Phase Separation, Self-Assembly, Electrospinning) ■ Growth Factor Delivery ■ CONCLUSIONS
- 3. INTRODUCTION ■ Alexis Carrel, winner of the Nobel Prize in Physiology or Medicine in 1912 and the father of whole-organ transplant, was the first to develop a successful technique for end to end arteriovenous anastomosis in transplantation. ■ The limitations of organ transplant because of immune reaction were recognized early. ■ To eliminate the need for immunosuppression, regenerative medicine and tissue engineering approaches have generally focused on using donor-derived autologous cells or cells that will not elicit an immune response. ■ However, terminally differentiated cells are typically limited in their ability to proliferate, and it is therefore difficult to obtain sufficient cell number for regeneration of tissues. In addition, cells from tissues to be treated or replaced are likely to have undesirable defects that require structural repair. ■ The characteristics that define stem cells- capacity for self-renewal, long-term proliferation, and the ability to differentiate into several different cell types—make them the optimal cell source for the development of new tissues and organs.
- 4. General schematic of tissue engineering strategy. (1) Cells are isolated from the patient and (2) expanded in 2D culture. (3) Expanded cells are then combined with various natural or engineered bioactive molecules (e.g., growth factors, nanoparticles, or DNA) into biocompatible scaffolds and (4) cultured in vitro under specific culture conditions to promote tissue formation. (5) Finally, functional tissue-engineered constructs are implanted into the donor to replace the damaged tissue.
- 6. Cell Therapy ■ With the rising popularity of stem cell research, cell therapy has evolved as a potential treatment method for a variety of conditions. Cell therapy involves delivery of cells either into the bloodstream or directly into the tissue of interest. Although tissue engineering strategies combine cells with scaffold materials and bioactive factors before implantation, cell therapy relies critically on the interaction of the donor cells with host tissues to restore function. ■ The greatest limitations in stem cell therapy are the low survival rates of the injected cells and the inability to closely control the location of those cells that do survive. Studies examining the effects of the delivery of MSCs after myocardial infarction have shown that the majority of cells injected intravenously were eventually found in the lungs, spleen, and liver, with only a small percentage of the cells engrafted into the injured heart wall.
- 7. Tissue Engineering and Biomaterials ■ Today, in addition to being biocompatible, biomaterials in tissue engineering applications have become increasingly sophisticated and are designed to meet several criteria. ■ First, they should provide appropriate mechanical strength to ensure that the tissue can withstand the normal forces it experiences or perform its physical functions in vivo. ■ Second, they must provide a compatible surface for cell attachment and appropriate topographic information. ■ Third, they should ideally be designed to degrade over a length of time that is appropriate for the specific application, such that ultimately, the engineered tissue is able to approximate its native state.
- 8. Bioactive Factors in Tissue Engineering ■ In addition to the cell source and scaffolds, the use of bioactive factors is important for the optimization of tissue-engineered constructs. Although the ECM provides the structural component of the native tissue, it also contains soluble bioactive factors, such as growth factors and cytokines, whose signals direct aspects of cell behavior, including survival, proliferation, migration, and differentiation. ■ A large number of in vitro studies have successfully used growth factors to direct differentiation of stem cells down specific cell lineages. However, it may be difficult to effectively control differentiation in vivo. Specifically, intravenous administration of growth factors may be undesirable and largely ineffective since repeated infusions of high concentrations of growth factors would be required due to the short half- life of the factors, which may lead to negative systemic effects.
- 9. Introduction to Nanotechnology ■ As more is learned about the mechanisms that control tissue growth and formation, it has become clear that the answer most likely lies in controlling the cell behavior at the nanoscale. Although complete in vitro recreation of the in vivo environment remains a somewhat distant target, this may not be necessary for success. Instead, it is important that we aim to understand the interactions between cells and their native environment and apply this knowledge to the development of constructs that will jumpstart tissue formation down the correct path before allowing the most effective incubator— the human body—to take over and remodel the engineered cells or constructs into the optimal structure.
- 10. Nano-Based Cell Tracking ■ Magnetic nanoparticles are commonly composed of superparamagnetic iron oxide (SPIO) particles 50–500 nm in diameter, which show enhanced contrast under magnetic resonance imaging (MRI). SPIO particles have been successfully used for cell tracking in stem cell therapy studies in animals and humans. Although initially it was thought that SPIO particles did not affect cell behavior, recent studies suggest that exposure to magnetic fields after labeling may alter adipogenic and osteogenic differentiation capacity. Further studies examining the effects on cells with SPIO particles under MRI are important before their clinical use. ■ Traditional fluorescent cell-labeling methods are limited by their lack of photostability, narrow excitation range, cell and tissue autofluorescence, and broad emission spectra. Quantum dots, or Q-dots, are fluorescent nanoparticles with diameters that typically range from 2 to 5 nm and can be synthesized in any color. Q-dots have greater photostability and a narrower emission profile than traditional fluorescent dyes, and they can be linked to specific proteins or DNA sequences to monitor specific cell behaviors.
- 11. 2D Nanotopography ■ One of the most common integrin binding sequences is the arginine- glycineaspartic acid (RGD) sequence. By modifying a substrate with the RGD peptide, cell adhesion, proliferation, and migration can be altered. Because obtaining substantial quantities of purified proteins is difficult and may cause adverse host immune responses, the use of short synthetic peptides that are not recognized by the host’s immune system but still contain functional domains to modulate cell adhesion to scaffolds is an attractive method for tissue engineering. ■ Studies using surfaces modified to have nanoscale features or express specific cell-adhesion peptides provide a highly organized way of examining cell behavior with topographic and biochemical cues and give important insights into the interactions of cells with textured surfaces. However, these substrates are limited in their complexity compared to the native tissue environment.
- 12. 3D Nanoscaffolds ■ Extensive studies have shown that there are clear differences in cell behavior and tissue formation on flat surfaces compared with 3D ECM scaffolds and that these differences occur at the protein and subprotein level. ■ The goal in successful application of 3D tissue engineered scaffolds is to identify and enhance key components that will provide the appropriate signals to cells to generate a functional tissue that can be translated into clinical use.
- 13. Phase Separation ■ Thermally induced phase separation (TIPS) is a technique that is particularly useful for generating scaffolds with a specific pore size. In this method, the temperature of the polymer solution is adjusted to a point at which a “polymer- rich” and a “polymer-poor” phase is generated. The solvent is removed, and the polymer-rich phase solidifies, forming a porous solid structure, which is then freeze dried. Nanofibrous scaffolds with varying fiber diameters and pore sizes can be generated by adjusting the polymer concentration, the type of solvent, and the phase separation temperature. Specifically, fibers ranging from 50 to 500 nm in diameter—similar to the size of native collagen—can be produced. Additionally, highly controlled interconnected macroporosity can be introduced by pouring the polymer solution over a negative wax mold, which is removed after solidification of the polymer.
- 14. Scaffolds created using thermally induced phase separation derived from three dimensional reconstructions of computed tomography (CT) scans. (a) Human ear reconstructed from histological sections and (b) the resulting nanofiber scaffold (scale bar¼10mm). (c) Human mandible reconstruction from CT scans and (d) resulting nanofiber scaffold (scale bar¼10mm). (e) Scanning electron micrographs showing interconnected spherical pores within mandible segment (scale bar¼500mm) and (f) nanofiber pore morphology within a single pore (scale bar¼5mm).
- 15. Electrospinning ■ Electrospinning has recently become the most commonly used method for the fabrication of nanofibrous biomaterials. This method involves the application of a high electric field to a polymer solution delivered at a constant rate through a needle. At a high enough voltage, the charge on the polymer overcomes the surface tension of the solution and causes emission of a fine polymer jet. This jet undergoes a whipping process, and the fibers are further elongated as the solvent evaporates and fibers are deposited on a grounded collector. ■ Both natural and synthetic polymer scaffolds have been successfully created using the electrospinning method. The ability to generate three-dimensional scaffolds with tailored architecture, mechanical properties, and degradation characteristics has made electrospinning a popular method in tissue engineering applications.
- 16. Fabrication of electrospun nanofibers. (a) General electrospinning setup consisting of syringe filled with polymer solution that is pumped through a needle charged with a high-voltage power supply. When the electrostatic forces between the collector and the solution overcome the surface tension of the solution, the solution is pulled out of the Taylor cone into fine fibers that are deposited on the grounded collector. (b) Scanning electron microscopic image of randomly arranged poly(e- caprolactone) (PCL) nanofibers formed by electrospinning (scale bar¼20mm). (c) Fluorescent image of mesenchymal stem cells seeded on nanofibers. Green, cells (membrane label); red, nanofibers; blue, cell nuclei (DAPI stain); scale bar¼20 mm.
- 17. Self-Assembly ■ Another method of generating nanofibrous scaffolds that mimic the structure of the ECM is through self-assembly of peptide amphiphiles (PAs). This is a bottom-up approach that mimics natural processes such as nucleic acid and protein synthesis. PAs are short peptide structures that spontaneously aggregate into cylindrical micelles approximately 5–8 nm in diameter and 1mm in length. This process occurs through noncovalent bonds under specifically tailored conditions. The peptides are typically composed of a hydrophobic alkyl chain tail, which forms the inside core of the fiber, and a hydrophilic head composed of epitopes, such as RGD, typically found in the native ECM that face outward, and interact with cells or other components of the ECM.
- 18. General structure of self-assembled peptide amphiphile (PA). (a) Molecular model of the PA showing the overall shape of the molecule. The narrow gray area represents the hydrophobic alkyl tail and the thicker head region is composed of hydrophilic amino acids containing functional groups that can provide signals to the cells to influence their behavior. (b) The PAs self-assemble into nanofibrous structures upon exposure to physiological conditions with the hydrophobic tail in the core and the head region facing the outside to interact with cells. (c) Vitreous ice cryotransmission electron microscopy image of hydrated PA fibers (scale bar¼200 nm).
- 19. Growth Factor Delivery ■ Although the scaffold structure plays an essential role in controlling cell behavior, chemical or biological modulators of cell activity and phenotype heavily influence tissue formation both in vitro and in vivo. In native tissues, growth factors provide specific signals to cells that direct cell activities, including cell migration, proliferation, and differentiation. The effects of growth factors are quite complex and are dependent on the concentration of the growth factor, phenotype of the cells acted on by the growth factor, and functional characteristics of the specific cell receptor interacting with the growth factor. ■ Heparin is a sulfated glycosaminoglycan that has a strong affinity for a number of growth factors, including basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and transforming growth factor-b (TGF-b). In one study, low-molecular weight heparin was conjugated to a poly(ethylene glycol) (PEG) carrier and electrospun with either PEO or poly(lactide-co-glycolide) followed by successful adsorption of bFGF.
- 20. ■ The ultimate goal in regenerative medicine and tissue engineering is to develop technologies to repair or replace tissues without the complication of chronic immunosuppression and dependence on organ donors. The key to success is understanding of how native tissues function and applying this information to establish the proper combination of cellular, structural, and chemical components that will allow for functional tissue development. CONCLUSIONS
- 21. Micro and Nano engineering approaches to develop gradient biomaterials suitable for interface tissue engineering ■ Salt leaching ■ Gas foaming ■ Phase separation ■ Emulsification ■ Solid free form technology ■ Photolithography ■ Microfluidics ■ Microcontact printing ■ Electrospining ■ Nanoimprint lithography